Moderna says its Covid vaccine has strong results in children ages 6 to 11.
Moderna Inc. said on Monday its Covid-19 vaccine generated a strong immune response and was generally well-toleratedThe company said it planned to submit the data to U.S., European and other regulators soon.Moderna said the data showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
The majority of side effects were mild or moderate in severity, the company said. The most common solicited adverse events were fatigue, headache, fever and injection site pain.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
FDA says Pfizer Covid vaccine benefits outweigh risks for kids ages 5 to 11Pfizer vaccine benefits for preventing hospitalizations and death from Covid-19 outweigh any serious potential side effects in children ages 5 to 11, FDA says.
続きを読む »
Pfizer Says Its COVID Vaccine Is More Than 90% Effective In Kids Ages 5-11Pfizer Says Its COVID Vaccine Is More Than 90% Effective In Kids Ages 5-11 “Data submitted by Pfizer shows that a reduced dose of its COVID vaccine is extremely protective for kids ages 5 to 11.”
続きを読む »
Fresh lockdowns in China as local Covid-19 infections spread to 11 provincesAuthorities in northern China are reimposing lockdowns and other emergency measures to curb the spread of coronavirus, with health officials warning of a worsening outbreak after the country recorded more than 100 cases across 11 provinces over the last week.
続きを読む »
Covid: Travellers now able to use cheaper Covid testsFully-jabbed people returning to England can now take lateral flow tests instead of PCR tests.
続きを読む »
China cancels Wuhan Marathon as Covid cases surgeChinese authorities have been racing to contain virus infections via mass testing of residents and targeted lockdowns.
続きを読む »
Italy’s Covid-19 Mandates Highlight Challenges for U.S. and OthersStrict Covid-19 vaccine requirements for workers have sparked protests in Italy, despite support from most people. WSJ's Eric Sylvers reports from Milan, where
続きを読む »